Claude-led discovery could represent a new gene-editing mechanism
Anthropic’s Dario Amodei says Claude analyzed literature and genome data, then proposed experiments that humans performed. He cautions that the molecular system’s precise function, biotech utility and significance remain unclear.
TLDR
On September 23, 2026, Anthropic’s Dario Amodei announced a Claude-led discovery of a molecular machine involving reverse transcriptase enzymes. He said the life sciences team suggested a broad research area, Claude identified something interesting and proposed experiments, and humans carried them out. Amodei described the work as mostly—but not entirely—Claude’s. He said the system could represent a new gene-editing mechanism, but its precise function, usefulness for biotechnology and significance were not yet clear.
Combined views
206
2 Sources, first seen 13h ago
Claude-led discovery could represent a new gene-editing mechanism
Anthropic’s Dario Amodei says Claude analyzed literature and genome data, then proposed experiments that humans performed. He cautions that the molecular system’s precise function, biotech utility and significance remain unclear.